News Releases

May 13, 2021
First quarter 2021 revenue of $11.9 million First quarter 2021 operating earnings of $5.4 million ; EPS of $0.19 Eton now has three commercial, revenue-generating products DEER PARK, Ill. , May 13, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical
February 8, 2021
Eton to receive up to $45 million plus royalties on product sales DEER PARK, Ill. , Feb. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON ), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today
Displaying 1 - 10 of 11